Abstract
The prevalence rate of smoking is well documented in the general population, but little is known among patients with Congestive Heart Failure (CHF). The mortality rate of CHF in San Bernardino county is nearly double (18.7 per 100,000 deaths) than that of the State of California (10.8 per 100,000 deaths). There is a need to fill knowledge gaps for CHF patients and identify evidence-based interventions that will help reduce health disparities among populations.
Highlights
The prevalence rate of smoking is well documented in the general population; little is known about cigarette smoking among patients with Congestive Heart Failure (CHF)
Findings showed an alarming prevalence rate (27%) of smoking among adult CHF patients seen at the McKee Family Health Center (FHC) compared to the general population’s prevalence rates (16.8%) for the country [5] and (11.7%) for the State of California [7]
Knowing that cigarette smoking has continually been shown as a key risk factor for heart disease morbidity and mortality, this study presented an even more urgent need to formulate effective evidence-based interventions for the McKee FHC patients and other CHF patients in the country
Summary
The prevalence rate of smoking is well documented in the general population, but little is known among patients with Congestive Heart Failure (CHF). The mortality rate of CHF in San Bernardino county is nearly double (18.7 per 100,000 deaths) than that of the State of California (10.8 per 100,000 deaths). The prevalence rate of smoking is well documented in the general population; little is known about cigarette smoking among patients with Congestive Heart Failure (CHF). The mortality rate of CHF in California alone was 10.8 per 100,000 deaths while that of San Bernardino County was almost double the state’s statistic at 18.7 - 31.6 per 100,000 [4]. The United States spends an average of $32 billion per year on the provision of treatment services, disease management, and missed productivity time from work for patients with CHF [3].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
